期刊文献+

吡格列酮对胰岛素抵抗细胞糖代谢糖异生的影响

Effect of pioglitazone on glymetabolism and glyconeogenesis in insulin resistance cells
下载PDF
导出
摘要 目的:研究吡格列酮对胰岛素抵抗细胞糖代谢糖异生的影响。方法:采用地塞米松诱导3T3-L1脂肪细胞复制胰岛素抵抗模型,观察吡格列酮对胰岛素抵抗细胞葡萄糖消耗、糖异生的影响。结果:吡格列酮能显著增加胰岛素抵抗细胞的葡萄糖消耗,并且与胰岛素有协同抑制胰岛素抵抗3T3-L1脂肪细胞糖异生的作用。结论:吡格列酮可通过抑制糖异生途径改善胰岛素抵抗细胞的糖代谢。 Objective: To investigate the effect of Pioglitazone on glymetabolism and glyconeogenesis with insulin resistance ceils. Methods: To observe the impact of Pioglitazone on glymetabolism and glyeoneogenesis with insulin-resistant 3T3-L1 adipoeytes cell model. Results: Pioglitazone significantly increased the consumption of glucose in insulin resistance cells, and the repression of glyconeogenesis by Pioglitazone in 3T3-L1 adipoeytes cell can supported by the addition of insulin. Conclusion: Pioglitazone improve the glymetabolism through the glyconeogenesis pathway in insulin resistance cells .
出处 《四川生理科学杂志》 2010年第2期73-74,共2页 Sichuan Journal of Physiological Sciences
关键词 3T3-L1脂肪细胞 胰岛素抵抗 糖代谢 糖异生 3T3-L1 adipocytes Isulin resistant Glymetabolism Glyconeogenesis
  • 相关文献

参考文献10

  • 1Hideyuki S,Takehide O,Motonobu A,et al.Dexamethasone-Induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction[J].Diabetes,2000,49(10):1700-1708.
  • 2Koh EH,Kim MS,Park JY,et al.Peroxisome proliferator activated receptor(PPAR) apha activation prevents diabetes in OLETF rats comparison with PPAR gamma activation[J].Diabetes,2003,52(9):2331-2337.
  • 3Guan Y.PPAR family and its relationship to renla complications of the metbaolic syndrome.[J].J Am Soc Nephro1,2004,15(11):2801-2815.
  • 4SoaresA F,Guichardant M,Cozzone D,et al.Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes[J].Free Radic Biol Med,2005,38(7):882-889.
  • 5Nelson B A,Robinson K A,Buse M G.High glucose and gluosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes[J].Diabetes,2000,49(6):981-991.
  • 6AnilKumarK L,Marita A R.Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocyte[J].Br J Pharmacol,2000,130(2):351-358.
  • 7Xu A,Wong LC,Wang Y,et al.Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1adipocytes[J].FEBS Lett,2004,572(2-3):129-134.
  • 8Palmer RM,Bain PA,Southern BG.Dexamethasone-induced catabolism and insulin resistance in L6 myoblast are reversed by the removel of serum[J].Lomp Biochem physiol C,1990,97(2):369-372.
  • 9陈秋,夏永鹏,邱宗荫.吡格列酮对胰岛素抵抗HepG2细胞模型的药理学评价[J].中国药理学通报,2006,22(2):248-251. 被引量:33
  • 10杨桂枝,高小平,晏菊芳,欧可群.GOD-POD法微量化测定方法的建立及其在3T3-L1脂肪细胞和HepG2细胞糖摄取中的应用[J].四川解剖学杂志,2003,11(1):12-15. 被引量:45

二级参考文献9

  • 1Gurnell M,Savage DB,Chatterjee VK et al.The metabolic syndrome:Peroxisome proliferator-activated receptor gamma and its therapeutic modulation[J].J Clin Endocrinol Metab,2003,88(6):2412-21.
  • 2Tadayyon M,Smith SA.Insulin sensitisation in the treatment of Type diabetes[J].Expert Opin Investig Drugs,2003,12(3):307-24.
  • 3Melin B,Cherqui G,Blivet MJ et al.Dual effect of metformin in cultured rat hepatocytes:potentiation of insulin action and prevention of insulin-induced insulin resistance[J].Metabolism,1990,39:1089.
  • 4Arakawa K,Ishihara T,Auto M et al.Action of novel antidiabetic thiazolidinedione,T-174,in animals of non-insulin-dependent diabetes mellitus(NIDDM) and in cultured muscle cells[J].Br J Pharmacol,1998,125:429-36.
  • 5Senn JJ,Klover PJ,Nowak IA et al.Interleukin-6 induces cellular insulin resistance in hepatocytes[J].Diabetes,2002,51(12):3391-9
  • 6Bernal MC,Weng S,Finck BN et al.Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice[J].Nat Med,2003,9(8):1069-75.
  • 7Camp HS.Thiazolidinediones in diabetes:Current status and future outlook[J].Curr Opin Investig Drugs,2003,4(4):406-11.
  • 8Santure M,Pitre M,Nadeau A et al.Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats[J].Metabolism,2003,52(8):978-86.
  • 9Julia A,Barman B,Greg L.Rosiglitazone[J].Drugs,1999,57:921-7.

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部